Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Healthtrust
Citi
Daiichi Sankyo
Colorcon
US Army
Julphar
Cantor Fitzgerald
Accenture

Generated: August 17, 2017

DrugPatentWatch Database Preview

Actavis Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS INC, and what generic and branded alternatives to ACTAVIS INC drugs are available?

ACTAVIS INC has five approved drugs.



Summary for Applicant: Actavis Inc

Patents:0
Tradenames:5
Ingredients:5
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Inc
GEMCITABINE HYDROCHLORIDE
gemcitabine hydrochloride
INJECTABLE;INJECTION204549-001Apr 11, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Inc
METHOXSALEN
methoxsalen
CAPSULE;ORAL202603-001Jun 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Inc
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION203622-002Jun 27, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Inc
GEMCITABINE HYDROCHLORIDE
gemcitabine hydrochloride
INJECTABLE;INJECTION204549-002Apr 11, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Inc
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION204686-001Oct 17, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Chubb
Federal Trade Commission
Merck
QuintilesIMS
Chinese Patent Office
Julphar
Baxter
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot